Global Red Biotechnology 麻豆原创 Research Report 2024

Publication ID:

PB501247502

Publication Date:

January 31, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Red biotechnology听is also known as biopharmaceuticals. It involves the application of biotechnology to produce medicine and drugs.
The global Red Biotechnology market was valued at US$ 275370 million in 2023 and is anticipated to reach US$ 358800 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
North American market for Red Biotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Red Biotechnology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Red Biotechnology in Biopharmaceutical Production is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Red Biotechnology include F. Hoffmann-La Roche, Amgen, Gilead Sciences, CSL and Pfizer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Red Biotechnology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Red Biotechnology.
Report Scope
The Red Biotechnology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Red Biotechnology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Red Biotechnology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
F. Hoffmann-La Roche
Amgen
Gilead Sciences
CSL
Pfizer
Segment by Type
Antibody
Nucleic Acid
Protein
Other
Segment by Application
Biopharmaceutical Production
Gene Therapy
Pharmacogenomics and Genetic Testing
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Red Biotechnology companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Red Biotechnology 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibody
1.2.3 Nucleic Acid
1.2.4 Protein
1.2.5 Other
1.3 麻豆原创 by Application
1.3.1 Global Red Biotechnology 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Production
1.3.3 Gene Therapy
1.3.4 Pharmacogenomics and Genetic Testing
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Red Biotechnology 麻豆原创 Perspective (2019-2030)
2.2 Red Biotechnology Growth Trends by Region
2.2.1 Global Red Biotechnology 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Red Biotechnology Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Red Biotechnology Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Red Biotechnology 麻豆原创 Dynamics
2.3.1 Red Biotechnology Industry Trends
2.3.2 Red Biotechnology 麻豆原创 Drivers
2.3.3 Red Biotechnology 麻豆原创 Challenges
2.3.4 Red Biotechnology 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Red Biotechnology Players by Revenue
3.1.1 Global Top Red Biotechnology Players by Revenue (2019-2024)
3.1.2 Global Red Biotechnology Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Red Biotechnology 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Red Biotechnology Revenue
3.4 Global Red Biotechnology 麻豆原创 Concentration Ratio
3.4.1 Global Red Biotechnology 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Red Biotechnology Revenue in 2023
3.5 Red Biotechnology Key Players Head office and Area Served
3.6 Key Players Red Biotechnology Product Solution and Service
3.7 Date of Enter into Red Biotechnology 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Red Biotechnology Breakdown Data by Type
4.1 Global Red Biotechnology Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Red Biotechnology Forecasted 麻豆原创 Size by Type (2025-2030)
5 Red Biotechnology Breakdown Data by Application
5.1 Global Red Biotechnology Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Red Biotechnology Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Red Biotechnology 麻豆原创 Size (2019-2030)
6.2 North America Red Biotechnology 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Red Biotechnology 麻豆原创 Size by Country (2019-2024)
6.4 North America Red Biotechnology 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Red Biotechnology 麻豆原创 Size (2019-2030)
7.2 Europe Red Biotechnology 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Red Biotechnology 麻豆原创 Size by Country (2019-2024)
7.4 Europe Red Biotechnology 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Red Biotechnology 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Red Biotechnology 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Red Biotechnology 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Red Biotechnology 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Red Biotechnology 麻豆原创 Size (2019-2030)
9.2 Latin America Red Biotechnology 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Red Biotechnology 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Red Biotechnology 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Red Biotechnology 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Red Biotechnology 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Red Biotechnology 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Red Biotechnology 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Detail
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Red Biotechnology Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Red Biotechnology Business (2019-2024)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Red Biotechnology Introduction
11.2.4 Amgen Revenue in Red Biotechnology Business (2019-2024)
11.2.5 Amgen Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Detail
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Red Biotechnology Introduction
11.3.4 Gilead Sciences Revenue in Red Biotechnology Business (2019-2024)
11.3.5 Gilead Sciences Recent Development
11.4 CSL
11.4.1 CSL Company Detail
11.4.2 CSL Business Overview
11.4.3 CSL Red Biotechnology Introduction
11.4.4 CSL Revenue in Red Biotechnology Business (2019-2024)
11.4.5 CSL Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Red Biotechnology Introduction
11.5.4 Pfizer Revenue in Red Biotechnology Business (2019-2024)
11.5.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

F. Hoffmann-La Roche
Amgen
Gilead Sciences
CSL
Pfizer

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.